1. Introduction {#s0005}
===============

The chemical element oxygen exists in eight well-characterized allotropic modifications: dioxygen (O~2~), ozone (O~3~), and the solid α-, β-, γ-, δ-, ε-, and ζ-oxygen phases (reviewed in [@bb0005]). The γ-, β-, and α-phases exist at ambient pressure (*p*  = 101.325 kPa) and low temperature (γ at *T*  \< 54.4 K; β at *T*  \< 43.8 K; α at *T*  \< 23.8 K) [@bb0005], [@bb0010]. At ambient temperature (*T*  = 295 K) under pressure of 5.4 GPa, oxygen solidifies into the β-phase, then at 9.6 GPa into the orthorhombic 'orange' δ-phase, and, successively, at 10 GPa into the monoclinic 'dark red' ε-phase. Above 96 GPa ε-oxygen is transformed into the metallic ζ-phase which exhibits superconductivity (*T* ~c~  = 0.6 K) [@bb0005], [@bb0010]. The 'red' ε-phase revealed the structure of two combined tetroxetane (cyclo-O~4~) rings, giving rise to rhombohedral O~8~ clusters [@bb0010]. In 1990, a ninth allotropic modification of oxygen was theoretically predicted [@bb0015], the cyclooctaoxygen (cyclo-O~8~, octoxocane) ([Fig. 1](#f0005){ref-type="fig"}A) [@bb0005], [@bb0015], assumed to exist in analogy to the common modification of elemental sulfur, cyclooctasulfur (cyclo-S~8~, octathiocane) [@bb0015]. We now wish to report the (biomimetic) synthesis, isolation, chemical characterization, biochemical and epigenetic significance of cyclo-O~8~ in the form of its sodium crown complex, (octoxocane-κ^4^ *O* ^1^,*O* ^3^,*O* ^5^,*O* ^7^)sodium(1 +) or cyclo-O~8~-Na^+^ ([Fig. 1](#f0005){ref-type="fig"}B), which can be liganded to give aqua(chloro)(octoxocane-κ^4^ *O* ^1^,*O* ^3^,*O* ^5^,*O* ^7^)sodium ([Fig. 1](#f0005){ref-type="fig"}C).Fig. 1Molecular modeling of cyclooctaoxygen and its Na^+^ complex. (A) The cyclo-O~8~ octagon (top, space-fill model; middle, crown conformation in *D*~4d~ symmetry; bottom, octagon). (B) Molecular modeling of the square pyramidal (*SPY*-4)-cyclo-O~8~-Na^+^ crown complex. (C) Molecular modeling of the trigonal prismatic cyclo-O~8~-Na^+^ crown complex, the (*TPR*-6)-aqua(chloro)(octoxocane-κ^4^*O*^1^,*O*^3^,*O*^5^,*O*^7^)sodium. In comparison to the cyclo-O~8~-Na^+^ crown complex (B), a symmetry transition in the O~8~ ring can be noted due to the thermodynamic *trans*-effect of the additional ligands.

2. Materials and methods {#s0010}
========================

2.1. Materials {#s0015}
--------------

β-D-Cytidine \[Lot: BCBL5271V; *w* (*n*/*n*) = 99.9% (HPLC), \[*α*\]~*D*~ ^20^  = + 33.0 (*c*  = 2 in H~2~O)\], anamorph yeast *Candida utilis* (HENNEBERG) LODDER et KREGER--van RIJ (1952) (*Saccharomycetaceae*) \[formerly: *Torula utilis* HENNEBERG (1926), *Torulopsis utilis* (HENNEBERG) LODDER (1934)\] low-molecular weight (*M* ~r~ 5000--8000) RNA (H^+^ form, a colloidal solution of 7 mg *C. utilis* low-molecular weight RNA in 800 μl H~2~O showed pH 3.8 at *ϑ*  = 13.8 °C) \[Lot: BCBN6317V; *w* (H~2~O) = 6% (*m*/*m*), *A* ~260 nm~/*A* ~280 nm~  = 1.86, *A* ~260 nm~/mg = 26.8\], and Atlantic salmon *Salmo salar* L. (*Salmonidae*) testes ssDNA colloidal solution (Na^+^ form, 100 μl salmon testes ssDNA colloidal solution diluted with 300 μl H~2~O showed pH 7.0 at *ϑ*  = 2--4 °C) \[Lot: SLBK6668V; 11 mg/ml in H~2~O (*A* ~260 nm~/mg = 25.0); ssDNA fragments generated by sonication of genomic DNA comigrate with marker fragments 587--831 bp\] were purchased from Sigma--Aldrich Corp. (St. Louis, MO). Ninhydrin *pro analysi* (p*K* ~a~ 9.3 ± 0.1) [@bb0020] \[Lot: 9N001522; *w* (*n*/*n*) = 99.80% (HPLC), pH (1%, H~2~O) 5.15 (20 °C), loss on drying 4.0% (this corresponds to the 0.412 hydrate)\], 2′-deoxy-β-D-cytidine hydrochloride \[Lot: 1F004920 and 4P014030; *w* (*n*/*n*) = 99.8% and 99.9%, respectively (HPLC), \[*α*\]~*D*~ ^20^  = + 56.2 and + 55.0, respectively (*c*  = 1 in H~2~O)\], and glacial acetic acid (acetic acid 100% *pro analysi*) \[Lot: 8Y002937; *w* (*m*/*m*) = 100.0% (titration), water 0.0% (Karl Fischer titration), acetic anhydride ≤ 0.05%, formic acid ≤ 0.01%, non-volatile matter ≤ 0.001%\] were purchased from PanReac AppliChem GmbH (Darmstadt, Germany). The 3% (*m*/*m*) aqueous H~2~O~2~ solution \[Deutscher Arzneimittel-Codex (DAC)/Neues Rezeptur-Formularium (NRF) monograph no. 11.103\] stabilized with 0.05% (*m*/*m*) *ortho*-phosphoric acid (H~3~PO~4~) (this solution showed pH 5.0 at *ϑ*  = 19.8 °C) was purchased from a local pharmacy (SaniPlus Apotheke im PEP, Munich, Germany). The 0.694 M sodium acetate buffer (pH 6.36 at *ϑ*  = 18.0 °C) was made by buffering 1.000 g of acetic acid *pro analysi* with sodium hydroxide (NaOH, 650 mg) in H~2~O (24 ml). Interferon alfacon-1 (INFERGEN™; Lot: 002586) was kindly provided by Intermune, Inc. (Brisbane, CA). Protease inhibitor EP128533 was kindly provided by Epicept Corp. (San Diego, CA).

2.2. Methods {#s0020}
------------

The FT--IR spectroscopy experiments were recorded in solid potassium bromide pellets on a Digilab Excalibur FTS 4000 spectrophotometer (Digilab, Inc., Holliston, MA), or neat by attenuated total reflectance (ATR) on a Nicolet iS5 FT--IR Spectrometer (Thermo Fisher Scientific, Inc., Waltham, MA). The FT--Raman spectroscopy experiments were recorded neat on a Bruker FT--Raman spectrometer RFS 100/S (Bruker Optics GmbH, Ettlingen, Germany). The Raman excitation source was a Nd:YAG--laser (*λ*  = 1064 nm). Given FT--IR absorbance and FT--Raman emission bands, both expressed in wavenumbers *ṽ* (cm^− 1^), are characterized in intensity as strong (str), middle (m), weak (w), and broad (br). The ^1^H-NMR (700.43 MHz) and ^13^C-Distortionless Enhancement by Polarization Transfer Including Detection of Quaternary Nuclei (DEPTQ) [@bb0025] NMR (176.12 MHz) spectroscopy experiments were recorded at a temperature of 25 °C using a Bruker Avance 700 NMR spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany). The spectra were referenced to the center of the NMR solvent signal \[^1^H-NMR: δ 2.51 (DMSO-*d* ~6~); ^13^C-NMR: δ 39.41 (DMSO-*d* ~6~)\]. Given chemical shifts δ \[from tetramethylsilane (TMS): δ = 0\] are specified as singlet (s), broad singlet (br s), doublet (d), triplet (t), doublet of doublet (dd), doublet of doublet of doublet (ddd), doublet of triplet (dt), quartet (q), and multiplet (m). ESI--MS was conducted in positive ion mode on a Synapt G2-Si high-resolution mass spectrometer equipped with an Acquity UPLC M-Class System (Waters Corp., Milford, MA) by direct loop injection. TLC was performed on pre-cut \[14.0 cm (height) × 11.5 cm\] Merck KGaA--EMD Millipore Corp. (Darmstadt, Germany) TLC silica gel 60-coated 20 × 20 cm aluminum sheets F~254~ (with fluorescence indicator 254 nm) with the eluent 80% (*v*/*v*) aqueous acetone in a Desaga standard TLC chamber (Desaga GmbH, Wiesloch, Germany) at room temperature (RT, *ϑ* ~∅~  = 14.1 ± 0.4 °C). The elution distance was 12.0 cm, and the elution time was 1 h 15 min. TLC spots were fan-dried at 30--50 °C, detected by UV--C light 254 nm, manually marked with pencil and photographed in the dark under UV--C illumination with a Kodak EasyShare **M**550 digital camera (Eastman Kodak Company, Rochester, NY). Elemental analyses (C, H, N, S, O) were conducted on the EURO EA3000 CHNS--O elemental analyzer (EuroVector SpA, Milan, Italy) by HEKAtech GmbH (Wegberg, Germany).

2.3. Software {#s0025}
-------------

Molecular modeling was performed with ACD/Chem Sketch version 12.01 with integrated ACD/3D Viewer (Advanced Chemistry Development, Inc., Toronto, Ontario, Canada) and processed with Mercury 3.1 version 3.1.1 \[The Cambridge Crystallographic Data Centre (CCDC), Cambridge, United Kingdom\].

2.4. Chemical synthesis {#s0030}
-----------------------

### 2.4.1. Cytidine hydrochloride {#s0035}

Cytidine (*M*  = 243.22 g/mol, 10.000 g, 41.1150 mmol) was dissolved in water (150 ml) supplied with 10.27 M \[32% (*m*/*m*)\] aqueous hydrochloric acid (4200 μl, 43.1340 mmol). Then acetone (1000 ml) was added. Afterwards, the crystallizing solution was cooled at + 0--2 °C for 3 h. The suspension was frozen at − 25 °C for 2.5 h. The evolved first yield (9.927 g) of the crystalline, white product was filtered and dried over CaCl~2~ *in vacuo*. Acetone (600 ml) was added to the filtrate, and it was frozen at − 25 °C for 18 h. The evolved second yield (266 mg) of the product was filtered and dried over CaCl~2~ *in vacuo*. The filtrate was frozen at − 25 °C for 28 h. The evolved third yield (217 mg) of the product was filtered and dried over CaCl~2~ *in vacuo*. All yields were combined (10.410 g, 91%). ^1^H-NMR (700 MHz, DMSO-*d* ~6~): δ 3.59 (dd, 1 H; ^2^ *J*  = − 12.2 Hz, ^3^ *J*  = 3.1 Hz; H-5′, pro-*R*), 3.71 (dd, 1 H; ^2^ *J*  = − 12.2 Hz, ^3^ *J*  = 3.1 Hz; H-5′, pro-*S*), 3.91 (dt, 1 H; ^3^ *J*  = 5.7 Hz, ^3^ *J*  = 2.9 Hz; H-4′), 3.97 (m, 1 H; H-3′), 4.05 (m, 1 H; H-2′), 5.71 (d, 1 H; ^3^ *J*  = 3.8 Hz; H-1′), 6.18 (d, 1 H; ^3^ *J*  = 7.6 Hz; H-5), 8.33 (d, 1 H; ^3^ *J*  = 8.0 Hz; H-6), 8.75 (br s, 1 H; 4-NH~2~, H~A~), 9.85 (br s, 1 H; 4-NH~2~, H~B~), 13.13 (br s, 1 H; 3-NH^+^); ^13^C-DEPTQ NMR (176 MHz, DMSO-*d* ~6~): δ 59.78 (C-5′), 68.74 (C-3′), 74.05 (C-2′), 84.62 (C-4′), 89.37 (C-1′), 93.64 (C-5), 144.29 (C-6), 146.98 (C-2), 159.32 (C-4); FT--IR (KBr): 3486 (m), 3342 (m), 3127 (str), 3064 (w), 2923 (m), 2906 (m), 2887 (m), 1721 (str), 1676 (str), 1538 (m), 1400 (m), 1277 (m), 1119 (str), 917 (w), 830 (m), 600 (m); FT--Raman (neat): 3127 (w), 3064 (w), 2960 (m), 2926 (m), 2869 (w), 1714 (w), 1674 (m), 1622 (w), 1537 (m), 1434 (w), 1399 (w), 1242 (str), 874 (m), 784 (str), 578 (w), 529 (w), 376 (w), 258 (w); analysis (% calcd, % found for C~9~H~13~N~3~O~5~•HCl) (*M*  = 279.68 g/mol): C (38.65, 38.69), H (5.05, 5.18), N (15.02, 14.98), O (28.60, 28.61). The NMR resonances were assigned according to literature data [@bb0030], [@bb0035].

### 2.4.2. Cytidine hydrochloride -- aqua(chloro)(octoxocane-κ^4^O^1^,O^3^,O^5^,O^7^)sodium (4:1) monohydrate hemiacetonate (**NC**) {#s0040}

Cytidine hydrochloride (*M*  = 279.68 g/mol, 2.660 g, 9.5109 mmol) and ninhydrin × 0.412 H~2~O (*M*  = 185.56 g/mol, 1.739 g, 9.3716 mmol) were dissolved in water (20 ml) supplied with 90% (*v*/*v*) aqueous ethanol (60 ml). The solution was refluxed for 90 min. Afterwards, the yellow solution was cooled at RT (*ϑ*  = 16.4 °C) for 10 min, then at + 0--2 °C for 50 min. Acetone (50 ml) was added, and the turbid solution was frozen at − 25 °C for 1 h. Afterwards, sodium hydroxide (380 mg, 9.5000 mmol) dissolved in water (3 ml) was added under stirring. An ultrashort color change to orange was visible. The resulting turbid yellowish solution was filtered through one layer of filter paper. Residues were transferred with acetone (200 ml) and ethyl acetate (EtOAc, 100 ml). The filtrate was frozen at − 25 °C for 2 h. EtOAc (200 ml) was added, and the suspension was frozen at − 25 °C for 1 h. Then 10.27 M \[32% (*m*/*m*)\] aqueous hydrochloric acid (1000 μl, 10.2700 mmol) was added under stirring to the suspension with sticky residues at the glass surface. Afterwards, the crystallizing suspension was frozen at − 25 °C for 15 h. The evolved yield of the white, crystalline product was filtered, washed on the filter with cold (+ 0--2 °C) EtOAc (100 ml), and dried over CaCl~2~ *in vacuo* (1.636 g, 50%). ^1^H-NMR (700 MHz, DMSO-*d* ~6~): δ 2.09 (s, 0.11 H; acetone CH~3~), 3.59 (dd, 1 H; ^2^ *J*  = − 12.2 Hz, ^3^ *J*  = 2.6 Hz; H-5′, pro-*R*), 3.70 (dd, 1 H; ^2^ *J*  = − 12.2 Hz, ^3^ *J*  = 2.6 Hz; H-5′, pro-*S*), 3.91 (m, 1 H; H-4′), 3.98 (t, 1 H; ^3^ *J*  = 5.1 Hz; H-3′), 4.05 (m, 1 H; H-2′), 5.71 (d, 1 H; ^3^ *J*  = 3.8 Hz; H-1′), 6.21 (d, 1 H; ^3^ *J*  = 8.3 Hz; H-5), 8.33 (d, 1 H; ^3^ *J*  = 7.7 Hz; H-6), 8.85 (br s, 1 H; 4-NH~2~, H~A~), 9.95 (br s, 1 H; 4-NH~2~, H~B~), 13.17 (br s, 1 H; 3-NH^+^); ^13^C-DEPTQ NMR (176 MHz, DMSO-*d* ~6~): δ 59.79 (C-5′), 68.77 (C-3′), 74.07 (C-2′), 84.66 (C-4′), 89.34 (C-1′), 93.66 (C-5), 144.25 (C-6), 147.00 (C-2), 159.49 (C-4); FT--IR (KBr): 3489 (str), 3417 (str), 3377 (str), 3322 (str), 3131 (m), 2921 (w), 1722 (str), 1717 (str), 1680 (str), 1538 (m), 1399 (w), 1277 (m), 1117 (m); FT--Raman (neat): 3127 (w), 3064 (w), 2960 (m), 2926 (m), 2869 (w), 1714 (w), 1674 (m), 1622 (w), 1537 (m), 1434 (w), 1398 (w), 1241 (str), 874 (m), 784 (str), 578 (w), 530 (w), 376 (w), 258 (w); analysis (% calcd, % found for 4C~9~H~14~ClN~3~O~5~•H~2~ClNaO~9~•H~2~O•½C~3~H~6~O) (*M*  = 1370.22 g/mol): C (32.87, 32.92), H (4.63, 4.61), N (12.27, 12.31), O (35.61, 24.48). The NMR resonances were assigned according to literature data [@bb0030], [@bb0035]. The exact cation mass was calculated according to literature data [@bb0040].

### 2.4.3. 2′-Deoxycytidine hydrochloride -- aqua(chloro)(octoxocane-κ^4^O^1^,O^3^,O^5^,O^7^)sodium (2:1) dihydrate (**dNC**) {#s0045}

2′-Deoxycytidine hydrochloride (*M*  = 263.68 g/mol, 2.660 g, 10.0880 mmol) and ninhydrin × 0.412 H~2~O (*M*  = 185.56 g/mol, 1.739 g, 9.3716 mmol) were dissolved in water (20 ml) supplied with 90% (*v*/*v*) aqueous ethanol (60 ml). The solution was refluxed for 90 min. Afterwards, the yellow solution was cooled at RT (*ϑ*  = 13.9 °C) for 10 min, then at + 0--2 °C for 50 min. Acetone (50 ml) was added, and the turbid solution was frozen at − 25 °C for 1 h. Afterwards, sodium hydroxide (380 mg, 9.5000 mmol) dissolved in water (3 ml) was added under stirring. An ultrashort color change to orange was visible. The resulting turbid yellowish solution was filtered through one layer of filter paper. Residues were transferred with acetone (200 ml) and EtOAc (100 ml). The filtrate was frozen at − 25 °C for 2 h. EtOAc (200 ml) was added, and the suspension was frozen at − 25 °C for 1 h. Then 10.27 M \[32% (*m*/*m*)\] aqueous hydrochloric acid (1,000 μl, 10.2700 mmol) was added under stirring to the suspension with sticky residues at the glass surface. Afterwards, the crystallizing suspension was frozen at − 25 °C for 15 h. The evolved yield of the white, crystalline product was filtered, washed on the filter with cold (+ 0--2 °C) EtOAc (100 ml), and dried over CaCl~2~ *in vacuo* (447 mg, 12%). From the filtrate, only 2′-deoxycytidine × HCl could be isolated (566 mg). ^1^H-NMR (700 MHz, DMSO-*d* ~6~): δ 2.13 (dt, 1 H; ^2^ *J*  = − 13.2 Hz, ^3^ *J*  = 6.4 Hz; H-2\'α), 2.22 (ddd, 1 H; ^2^ *J*  = − 13.4 Hz, ^3^ *J*  = 6.2 Hz, ^3^ *J*  = 4.0 Hz; H-2\'β), 3.56 (m, 1 H; H-5′, pro-*R*), 3.61 (m, 1 H; H-5′, pro-*S*), 3.84 (q, 1 H; ^3^ *J*  = 3.8 Hz; H-4′), 4.23 (m, 1 H; H-3′), 6.06 (t, 1 H; ^3^ *J*  = 6.1 Hz; H-1′), 6.18 (d, 1 H; ^3^ *J*  = 8.0 Hz; H-5), 8.24 (d, 1 H; ^3^ *J*  = 7.6 Hz; H-6), 8.75 (br s, 1 H; 4-NH~2~, H~A~), 9.83 (br s, 1 H; 4-NH~2~, H~B~), 13.11 (br s, 1 H; 3-NH^+^); FT--IR (KBr): 3401 (br str), 2923 (w), 1712 (m), 1670 (m), 1541 (w), 1422 (w), 1271 (m), 1087 (m), 845 (w), 771 (w), 673 (w), 610 (w), 564 (w); analysis (% calcd, % found for 2C~9~H~14~ClN~3~O~4~•H~2~ClNaO~9~•2H~2~O) (*M*  = 767.84 g/mol): C (28.16, 28.15), H, (4.46, 4.01), N (10.94, 10.78), O (39.59, 16.93). The ^1^H-NMR resonances were assigned according to literature data [@bb0045], [@bb0050].

### 2.4.4. Cytidine hydrochloride -- μ-chloro(μ-hydroxy)bis(octoxocane-κ^4^O^1^,O^3^,O^5^,O^7^)disodium (1:2) hemi(hemi)acetonate (**RC**) {#s0050}

Cytidine hydrochloride (*M*  = 279.68 g/mol, 315 mg, 1.1263 mmol) was dissolved in 3% (*m*/*m*) aqueous dihydrogen peroxide solution \[21 ml, 630 mg H~2~O~2~ (*M*  = 34.01 g/mol), 18.5240 mmol\] at RT, and 0.694 M sodium acetate buffer (pH 6.36, 10.5 ml) was added. The buffered solution was left standing at RT (*ϑ*  = 19.4 °C) for 10 min. Afterwards, solid low-molecular weight RNA (H^+^ form) from *Torula utilis* (syn. *C. utilis*) was added (147 mg). The light yellow solution was shaken and left standing at RT for 15 min. Afterwards, solid sodium hydrogen carbonate (NaHCO~3~, 336 mg, 4.000 mmol) was added. A heavy gas evolution of oxygen started through catalase effect mediated by cytidine and RNA. The solution was left standing closed at RT for 2 h (after 10 min standing, the mixture was shaken for 10 s under frothing). Afterwards, 10.27 M \[32% (*m*/*m*)\] aqueous hydrochloric acid (400 μl, 4.1080 mmol) and acetone (30 ml) were added under stirring. The precipitating suspension was frozen at − 25 °C for 1 h. Then the suspension was filtered through one layer of filter paper (in the filter the RNA remained). Residues were transferred and rinsed with acetone (20 ml). The slight yellowish and turbid filtrate was filtered through two layers of filter paper. Residues were transferred and rinsed with acetone (10 ml). The filtrate was mixed with acetone (150 ml), 10.27 M \[32% (*m*/*m*)\] aqueous hydrochloric acid (800 μl, 8.2160 mmol), and EtOAc (80 ml), and was frozen at − 25 °C for 1 h. Then EtOAc (60 ml) was added, and the mixture was frozen at − 25 °C for 1 h. Afterwards, acetone (200 ml) was added, and the suspension was shaken vigorously for 10 s. After freezing at − 25 °C for 2 h, 90% (*v*/*v*) aqueous ethanol (5 ml) was added, the suspension was shaken vigorously for 30 s, and was frozen at − 25 °C for 45 min. The evolved yield of the white, crystalline product was filtered, washed on the filter with cold (+ 0--2 °C) acetone (100 ml), and was dried over CaCl~2~ *in vacuo* (486 mg, 43%). ^1^H NMR (700 MHz, DMSO-*d* ~6~): δ 3.59 (dd, 1 H; ^2^ *J*  = − 12.5 Hz, ^3^ *J*  = 2.9 Hz; H-5′, pro-*R*), 3.70 (dd, 1 H; ^2^ *J*  = − 12.2 Hz, ^3^ *J*  = 2.6 Hz; H-5′, pro-*S*), 3.90 (dt, 1 H; ^3^ *J*  = 5.4 Hz, ^3^ *J*  = 2.6 Hz; H-4′), 3.97 (t, 1 H; ^3^ *J*  = 5.1 Hz; H-3′), 4.04 (t, 1 H; ^3^ *J*  = 4.5 Hz; H-2′), 5.71 (d, 1 H; ^3^ *J*  = 3.8 Hz; H-1′), 6.18 (d, 1 H; ^3^ *J*  = 7.7 Hz; H-5), 8.30 (d, 1 H; ^3^ *J*  = 8.3 Hz; H-6), 8.78 (br s, 1 H; 4-NH~2~, H~A~), 9.83 (br s, 1 H; 4-NH~2~, H~B~), 13.19 (br s, 1 H; 3-NH^+^); FT--IR (neat): 3486 (str), 3342 (str), 3127 (str), 3063 (w), 2922 (m), 1718 (str), 1678 (str), 1538 (m), 1400 (m), 1277 (m), 1118 (m), 830 (w); analysis (% calcd, % found for C~9~H~14~ClN~3~O~5~•2HClNa~2~O~17~•¼C~3~H~6~O) (*M*  = 1003.06 g/mol): C (11.67, 11.50), H (1.76, 1.62), N (4.19, 4.06), O (62.61, 27.46).

2.5. Catalase effect assays {#s0055}
---------------------------

Assays were performed at RT (*ϑ* ~∅~  = 18.03 ± 0.10 °C). The detection of oxygen evolution was substantiated by visual inspection [@bb0055] of the gas bubble pearl chains over 5 min in an open glass reaction vessel (*V*  = 5 ml). Stock preparations were 3% (*m*/*m*) aqueous H~2~O~2~ solution stabilized with 0.05% (*m*/*m*) H~3~PO~4~, 0.694 M sodium acetate buffer pH 6.36, *C. utilis* low-molecular weight RNA (H^+^ form), and salmon testes ssDNA (Na^+^ form) colloidal stock solution (thawed for 1 h at RT from freezing at − 25 °C).

2.6. Binding of **NC** to C. utilis low-molecular weight RNA {#s0060}
------------------------------------------------------------

Stock preparations were cytidine × HCl (7 mg in 1000 μl H~2~O), **NC** (10 mg in 1000 μl H~2~O), and *C. utilis* low-molecular weight RNA (H^+^ form) colloidal stock solution (19 mg in 3000 μl H~2~O, not RNase-free).

2.7. Binding of **NC** to salmon testes ssDNA {#s0065}
---------------------------------------------

Stock preparations were cytidine × HCl (7 mg in 1000 μl H~2~O), **NC** (11 mg in 1000 μl H~2~O), and salmon testes ssDNA (Na^+^ form) colloidal stock solution (thawed for 45 min at RT from dry ice freezing).

2.8. Binding of **NC** to salmon testes ssDNA in presence of spermine × 1 ⅓ (sodium dihydrogen phosphate) × 9 H~2~O {#s0070}
-------------------------------------------------------------------------------------------------------------------

Stock preparations were cytidine × HCl (7 mg in 1000 μl H~2~O), **NC** (11 mg in 1000 μl H~2~O), and salmon testes ssDNA (Na^+^ form) colloidal stock solution (thawed for 30 min at RT from dry ice freezing). Spermine (free base, *M*  = 202.34 g/mol, 20 mg, 98.8435 μmol) and NaH~2~PO~4~  × 2 H~2~O (*M*  = 156.00 g/mol, 68 mg, 435.8974 μmol) were dissolved in 2000 μl H~2~O, after 1 min shaking at RT a white precipitate of spermine × 1 ⅓ (sodium dihydrogen phosphate) × 9 H~2~O evolved. The remainder of this precipitate was isolated, dried over CaCl~2~ *in vacuo* (28 mg, corrected for loss 68%), and subjected to elemental analysis. Analysis (% calcd, % found for C~10~H~26~N~4~•1⅓NaH~2~PO~4~•9H~2~O) (*M*  = 524.45 g/mol): C (22.90, 22.72), H (8.97, 8.98), N (10.68, 10.29), O (43.73, 43.71).

2.9. Calculation of genomic coverage by the first epigenetic shell of *in vivo* DNA in bovine lymphocytes {#s0075}
---------------------------------------------------------------------------------------------------------

The average volume of human lymphocytes was taken as 206 fl (206 μm^3^) [@bb0060]. The average volume of bovine lymphocytes was taken as 214 fl (femtoliter) after introducing a technical correction factor of *f*  = 0.834 [@bb0065]. The reference genome size of *Bos taurus* (Hereford breed) was taken as 2,670,139,648 bp (RefSeq assembly accession number GCF_000003055.6) [@bb0070]. This genome showed 41.89% GC content [@bb0070]. The theoretical intracellular concentration of the sperminium phosphate/cyclo-O~8~-Na^+^ complex required to cover all triplets of the dsDNA genome in a blood lymphocyte of *B. taurus* was calculated as \[214 fl × 6.022 × 10^23^ mol^− 1^\]^− 1^  × 2,670,139,648 × 2 × 3^− 1^  = 7.7597 pM × 1,780,093,099 = 13.8130 mM. The coverage of *B. taurus* genome by the sperminium phosphate/cyclo-O~8~-Na^+^ complex was calculated (as mean ± s.d.: 2.6208 ± 0.4953%) from the published [@bb0075] fractions of spermine bound to dsDNA: 421 μM × \[13.8130 mM\]^− 1^  = 3.0479% (in presence of 2 mM Mg^2 +^ and 100 mM K^+^), 287 μM × \[13.8130 mM\]^− 1^  = 2.0778% (2 mM Mg^2 +^, 150 mM K^+^), and 378 μM × \[13.8130 mM\]^− 1^  = 2.7366% (10 mM Mg^2 +^, 100 mM K^+^). The number of protein-coding exons in *B. taurus* genome was taken as 21,364 [@bb0080], and the number of base pairs for this number of genes with an average amino acid residue number/gene (empirical value: Ø 1100 amino acid residues/gene) was calculated as 21,364 × 3 bp × 1100 = 70,501,200 bp (2.6404% of *B. taurus* genome). An alternative calculation of the number of base pairs for protein-coding exons in *B. taurus* genome (52,038) [@bb0070] with the median of amino acid residues/gene (459) [@bb0070] was 52,038 × 3 bp × 459 = 71,656,326 bp (2.6836% of *B. taurus* genome). The GC content of *E. coli*-derived pBR322 plasmid covalently closed circular dsDNA (GenBank accession number [J01749.1](ncbi-n:J01749.1){#ir0005}) was calculated from its sequence as 53.75%.

2.10. Calculation of genomic coverage by the first epigenetic shell of *in vivo* DNA in HeLa S3 cells {#s0080}
-----------------------------------------------------------------------------------------------------

The average effective molecular mass of dGp/dCp was taken as *M*  = 309.19 g/mol, of dAp/dTp as *M*  = 308.70 g/mol. The reference *Homo sapiens* genome size was taken as 3,228,894,042 bp (RefSeq assembly accession number GCF_000001405.30) [@bb0085]. This genome showed 41.45% GC content [@bb0085]. The molecular mass of this human genome dsDNA was calculated as (0.4145 × 309.19 g/mol) + (0.5855 × 308.70 g/mol) × (3,228,894,042 bp × 2) = 308.90 g/mol × (3,228,894,042 bp × 2) = 1.994811 × 10^12^  g/mol. The HeLa cell genome [@bb0090] was anticipated as 76 chromosomes (hypertriploid) + 22 abnormal chromosomes [@bb0090], [@bb0095]. The diploid chromosomal DNA size of HeLa metaphase chromatin dsDNA was calculated as 19,539,129,390 bp with *M*  = 1.207127414 × 10^13^  g/mol from published karyotyping [@bb0095]. The content of spermine in HeLa S3 cell metaphase chromatin was taken as 135.9 ± 16.1 pmol/μg DNA [@bb0100]. This was transformed into 135.9 ± 16.1 p(ico)mol spermine/82.84129651 z(epto)mol dsDNA = 1,640,486,155 (molecules spermine/diploid genome). This corresponds to a coverage of 1,640,486,155 × 2^− 1^  × 3 × \[19,539,129,390\]^− 1^  = 12.5939% of HeLa S3 cell metaphase chromatin haploid genome by the sperminium phosphate/cyclo-O~8~-Na^+^ complex.

2.11. Calculation of genomic coverage by the first epigenetic shell of *in vivo* DNA in murine cryptal enterocytes {#s0085}
------------------------------------------------------------------------------------------------------------------

The phosphorus (P) content of murine cryptal enterocytic mitotic (late anaphase/early telophase) chromatin was taken as 298.5 ± 17.3 mmol (P)/kg [@bb0105]. The reference values for the phosphorus content were calculated as 3162.47 mmol (P)/kg (free DNA) and 2859.31 mmol (P)/kg (sperminium phosphate/cyclo-O~8~-Na^+^-complexed DNA), respectively, according to the formula *w* (P) = (*n* ~P~  × 1000 g) ×  *M* ^− 1^ (*n* ~P~, number of P atoms *pro* formula unit; *M*, molecular weight of formula unit). The reference value for the P content of phospholipid was calculated as 1362.32 mmol (P)/kg for (dipalmitoyl)phosphatidylcholine (*M*  = 734.04 g/mol), the main constituent (60.8 ± 1.3%) of the phospholipid fraction in rat liver chromatin [@bb0110]. The fractions of DNA (32.0 ± 4.1%), RNA (5.1 ± 1.6%), protein (62.6 ± 3.8%), and phospholipid (0.3 ± 0.1%) in mitotic chromatin of rodent liver cells were taken as published [@bb0110] and applied on the primary murine cryptal enterocytic mitotic chromatin nucleic acids (DNA + RNA). The published [@bb0105] value was corrected for the chromatin-bound cation (Na^+^, K^+^, Mg^2 +^, Ca^2 +^) [@bb0105], protein and phospholipid [@bb0110] content: {\[841.0 mmol (Na^+^, K^+^, Mg^2 +^, Ca^2 +^)/kg + 298.5 mmol (P)/kg\] × 100 × 37.1^− 1^} + \[0.3 × 100^− 1^  × 1362.32 mmol (P)/kg\] = 3075.52 mmol (P)/kg (DNA + RNA) in mitotic chromatin. The coverage (DNA + RNA) by the sperminium phosphate/cyclo-O~8~-Na^+^ complex was calculated as (3162.47--3075.52) × (3162.47--2859.31)^− 1^  × 100% = 28.6812%. The haploid genomic coverage by the sperminium phosphate/cyclo-O~8~-Na^+^ complex, corrected for the nuclear RNA content, was calculated as 28.6812% × (32.0 × 37.1^− 1^) × 2^− 1^  = 12.3693%. The coverage of nuclear RNA by the sperminium phosphate/cyclo-O~8~-Na^+^ complex was calculated as 28.6812% − (12.3693% × 2) = 3.9427%, corresponding to a relative coverage of 3.9427 × (5.1)^− 1^  × 100% = 77.3078%.

2.12. Cytotoxicity and HIV-1~LAI~ replication reverse transcriptase assays {#s0090}
--------------------------------------------------------------------------

The cytotoxicity and human immunodeficiency virus type 1 (HIV-1) strain LAI replication assays were performed in freshly explanted primary human peripheral blood mononuclear cells (PBM cells) according to published procedures [@bb0115]. The assays were conducted at least in triplicate and treated statistically (if possible).

2.13. Cytotoxicity and HBV ayw antiviral assays {#s0095}
-----------------------------------------------

The cytotoxicity and human hepatitis B virus (HBV) subtype ayw replication assays were performed in HepAD38 cells (HepG2 hepatoblastoma cell-derived, stably transfected cell line, producing HBV subtype ayw under control of a tetracycline-responsive promoter) according to published procedures [@bb0120]. The assays were conducted in triplicate and treated statistically.

2.14. Cytotoxicity and influenza A virus replication antiviral assays {#s0100}
---------------------------------------------------------------------

The cytotoxicity and influenza A/California/07/2009 (pandemic swine-origin H1N1, resistant to amantadine due to a S31N mutation in M2 protein [@bb0125]) and influenza A/duck/Minnesota/1525/81 (low pathogenic avian influenza H5N1, amantadine-susceptible, kindly provided by Dr. Robert G. Webster, St. Jude Children\'s Research Hospital, Memphis, TN) antiviral assays were performed utilizing the neutral red assay, and the virus yield reduction assay, in *Madin*--*Darby* canine kidney (MDCK) cells according to published procedures [@bb0130]. The assays were conducted in triplicate and treated statistically.

2.15. Cytotoxicity and chikungunya virus replication antiviral assays {#s0105}
---------------------------------------------------------------------

The cytotoxicity and chikungunya virus (*Togaviridae*, *Alphavirus*, SFV complex) strain S-27 \[ATCC® VR-64™, obtained from American Type Culture Collection (ATCC), Manassas, VA\] antiviral assays were performed utilizing the neutral red assay, and the virus yield reduction assay, in Vero 76 cells. The cells were maintained in MEM (MEM/EBSS, Hyclone, Logan, UT) supplemented with 5% fetal bovine serum (FBS). **NC** was dissolved in dimethyl sulfoxide (DMSO) at 20 mM and then further diluted in the test medium half log dilutions to a final DMSO concentration of ≤ 5% DMSO with 1000, 320, 100, 32, 10, 3.2, 1.0, and 0.32 μM of the compound for antiviral testing. The utilized positive control was interferon alfacon-1 (INFERGEN™), a consensus interferon-α 1. The assays were conducted in triplicate and treated statistically.

2.16. Cytotoxicity and MERS coronavirus replication antiviral assays {#s0110}
--------------------------------------------------------------------

The cytotoxicity and Middle East respiratory syndrome (MERS) coronavirus (*Nidovirales*, *Coronaviridae*, *Coronavirinae*, *Betacoronavirus*) strain human coronavirus Erasmus Medical Center/2012 (HCoV-EMC/2012) were performed utilizing the neutral red assay in Vero 76 cells. The cells were maintained in MEM (MEM/EBSS, Hyclone, Logan, UT) supplemented with 5% fetal bovine serum (FBS). As a positive control served the protease inhibitor (4*RS*)-4-\[*N*-(benzyloxycarbonyl)-L-leucylamino\]-6-fluoro-5-oxohexanoic acid *N*,*N*-dimethylamide (EP128533) [@bb0135]. The assays were conducted in triplicate and treated statistically.

2.17. Neutral red assay {#s0115}
-----------------------

**NC** was evaluated for cytotoxicity and inhibition of virus-induced cytopathic effect (CPE) using the neutral red lysosomal uptake cell viability assay [@bb0140] essentially as described previously [@bb0145], [@bb0150]. Briefly, cells were seeded into 96-well plates for the *in vitro* assays and incubated at 37 °C with 5% CO~2~ before testing so that cells were 80--100% confluent upon infection. Each dilution of test or control compound was added to 5 wells of a 96-well plate, and three wells of each dilution were then infected with the test virus. The multiplicity of infection (MOI) was ≤ 0.007 cell culture infective dose 50% (CCID~50~)/cell for each virus. Two wells remained uninfected as toxicity controls. Six wells per plate were set aside as uninfected, untreated cell controls, and six wells per plate were infected with no treatment as virus controls. A known active compound was assayed in parallel as a control. The test medium was MEM with 2% FBS for chikungunya virus and MERS coronavirus, and MEM with 1 IU/ml trypsin and 10 μg/ml of EDTA for influenza A viruses. Assay plates were incubated at 37 °C with 5% CO~2~. After 3 days, when CPE was observed microscopically, each well was filled with 0.011% (*m*/*v*) neutral red, a vital stain, and the plate was incubated for ≈ 2 h at 20--25 °C. The unincorporated neutral red solution was removed from the wells and the incorporated dye was then eluted by adding Sørensen citrate-buffered ethanol. The plates were then read on a spectrophotometer at *λ*  = 540 nm wavelength to quantify the neutral red taken up by the healthy cells. The optical density of test wells was converted to percent of cell control and normalized to the virus controls. The concentration of test compound required to inhibit CPE by 50% (EC~50~) was calculated by regression analysis. The concentration of compound that would cause 50% CPE in the absence of virus (CC~50~) was also calculated by regression analysis using the uninfected wells treated with test compounds compared with untreated cell controls. The selectivity index 50% (SI~50~) is the CC~50~ divided by EC~50~. Assays were conducted in triplicate, and the arithmetic mean values ± standard deviation (s.d.) were calculated.

2.18. Virus yield reduction assay {#s0120}
---------------------------------

The virus yield reduction assay determines actual virus yield in the presence and absence of the test compound; this is the confirmatory assay for antiviral activity and was performed on influenza A and chikungunya viruses. After 3 days\' incubation when maximum CPE was observed in the neutral red assay plates, an aliquot of supernatant fluid was removed from each test well. Replicate wells of each compound concentration or control were pooled and frozen at − 80 °C. Samples were thawed and diluted by 10-fold serial dilutions. A 100 μl aliquot of each dilution was then plated onto 4 replicate wells of 96-well plates seeded with the applicable cells for each virus strain. Plates were incubated as noted above until viral CPE reached its endpoint, then each well was scored microscopically for the presence of viral CPE. The virus titer was determined based on the endpoint using the *Reed*--*Muench* method [@bb0155]. Test wells were compared with virus control wells, and the concentration of compound required to reduce virus yield by 90% or 1 log~10~ (EC~90~) was calculated by regression analysis. Assays were conducted in (at least) triplicate, and the arithmetic mean values ± standard deviation (s.d.) were calculated.

3. Results {#s0125}
==========

3.1. Synthesis and characterization of **NC** {#s0130}
---------------------------------------------

In an endeavor to gain new antiviral substances, the reported reaction [@bb0160] of the ribonucleic acid (RNA) nucleoside cytidine with ninhydrin on reflux was re-examined. Instead of cytidine, cytidine hydrochloride (cytidine × HCl) was utilized ([Fig. 2](#f0010){ref-type="fig"}A). The reported reaction [@bb0160] did not proceed, instead a crystalline material **NC** could be isolated which gave not the elemental analysis of cytidine × HCl. This striking difference of **NC** from cytidine × HCl was examined further by proton nuclear magnetic resonance (^1^H-NMR) spectroscopy (Fig. S1), *Fourier* transform infrared (FT--IR) spectroscopy (Fig. S2), FT--Raman spectroscopy (Fig. S3), and electrospray ionization mass spectrometry (ESI--MS) (Fig. S4A and Fig. S5). It could be substantiated that **NC** contained an inert material not being salt (NaCl), since the FT--IR spectrum of **NC** differed from that of cytidine × HCl. According to elemental analysis this inert material could account for one O~2~ and a quarter of NaCl *pro* one cytidine × HCl. In consequence, the formula was multiplied fourfold and this resulted in an oxygen 8-ring, cyclo-O~8~ ([Fig. 1](#f0005){ref-type="fig"}A), coordinated to one Na^+^ ([Fig. 1](#f0005){ref-type="fig"}B). The interpretation of the ESI--MS spectrum of **NC** actually proved the inclusion of cyclo-O~8~-Na^+^ in **NC**, revealing was the detection of the aqua(octoxocane-κ^4^ *O* ^1^,*O* ^3^,*O* ^5^,*O* ^7^)sodium(1 +) cation (Fig. S5). Since in the ^1^H-NMR spectrum of **NC**, in comparison to the ^1^H-NMR reference spectrum of cytidine × HCl, the differentially affected resonances were the 4-NH~2~, the 3-NH^+^, and the H-5 protons of the protonated cytidine (Fig. S1), it is assumed that the points of coordination between cyclo-O~8~-Na^+^ and cytidine × HCl are the two 4-NH~2~ hydrogens and one non-Na^+^-coordinated (free) oxygen of cyclo-O~8~-Na^+^. Consequently, a formula for **NC** can be elaborated: cytidine hydrochloride − aqua(chloro)(octoxocane-κ^4^ *O* ^1^,*O* ^3^,*O* ^5^,*O* ^7^)sodium (4:1) ([Fig. 2](#f0010){ref-type="fig"}A). The FT--Raman spectrum of **NC** (Fig. S3B) was nearly identical to the reference spectrum of cytidine × HCl (Fig. S3A). This, contrary to expectation, pointed to Raman-inactivity of cyclo-O~8~-Na^+^.Fig. 2The syntheses of cyclo-O~8~-Na^+^-containing complexes. (A) Synthesis of the cyclo-O~8~-Na^+^-containing complex **NC** by refluxing cytidine × HCl with ninhydrin under influence of atmospheric O~2~. (B) Synthesis of the cyclo-O~8~-Na^+^-containing complex **dNC** by refluxing 2′-deoxycytidine × HCl with ninhydrin under influence of atmospheric O~2~. (C) Biomimetic synthesis of the cyclo-O~8~-Na^+^-containing complex **RC** through reaction with buffered 3% H~2~O~2~ as catalyzed (catalase effect) by *C. utilis* low-molecular-weight RNA and NaHCO~3~ at ambient temperature and physiological pH. (D) Proposed synthesis mechanism for the generation of cyclo-O~8~ from atmospheric O~2~ under ninhydrin catalysis over the 10-ring intermediate spiro\[indene-2,10′-nonoxecane\]-1,3-dione.

3.2. Synthesis and characterization of **dNC** {#s0135}
----------------------------------------------

The new ninhydrin reaction was in turn applied on 2′-deoxycytidine hydrochloride (2′-deoxycytidine × HCl) ([Fig. 2](#f0010){ref-type="fig"}B). A crystalline material **dNC** could be isolated which gave not the elemental analysis of 2′-deoxycytidine × HCl. The FT--IR spectrum of **dNC** differed from that of 2′-deoxycytidine × HCl (Fig. S6). The interpretation of the ESI--MS spectrum (Fig. S4B and Fig. S7) of **dNC** proved the inclusion of cyclo-O~8~-Na^+^ in **dNC**. The detection of the {octoxocane + (2′-deoxycytidine)~*m*~  + 4-amino-1-\[(2*R*)-2,5-dihydrofuran-2-yl\]pyrimidin-2(1*H*)-one + H}^+^ (*m*  = 0, 1, 2) cations proved the existence of cyclooctaoxygen for the first time. In analogy to **NC**, supported by ^1^H-NMR spectroscopy of **dNC** (Fig. S8A), a formula for **dNC** can be constructed: 2′-deoxycytidine hydrochloride − aqua(chloro)(octoxocane-κ^4^ *O* ^1^,*O* ^3^,*O* ^5^,*O* ^7^)sodium (2:1) ([Fig. 2](#f0010){ref-type="fig"}B).

3.3. Catalase assay with **NC** and *Candida utilis* RNA {#s0140}
--------------------------------------------------------

Next, it was questioned if cyclo-O~8~-Na^+^ could be produced in biomimetic reactions, and it was considered that in the two ninhydrin reactions ([Fig. 2](#f0010){ref-type="fig"}A, B), atmospheric oxygen was the source of the oxygen atoms in cyclo-O~8~. Our interest concentrated on oxygen formation by possible catalase effects under physiological conditions. The catalase effect is the disproportionation of dihydrogen peroxide (H~2~O~2~) into oxygen and water: 2 H~2~O~2~ → O~2~  + 2 H~2~O. As a catalyst RNA was selected, since RNA can exhibit enzymatic (ribozyme) activities *in vivo* [@bb0165]. The selected RNA was *Candida utilis* anamorph yeast low-molecular weight RNA. This RNA consists of transfer RNAs (tRNAs) and the *C. utilis* 5S ribosomal RNA (rRNA) [@bb0170], [@bb0175]. As a result, it was discovered that **NC** catalyzed oxygen formation from H~2~O~2~ (catalase effect) [@bb0055] weakly in presence of NaHCO~3~, and strongly in presence of both *C. utilis* RNA and NaHCO~3~ (Fig. S9). Interestingly, **NC** could be fully substituted by cytidine × HCl. Multiple controls assured that oxygen neither was produced spontaneously, nor from any other relevant combination of the utilized reagents. Taken together, the nucleoside cytidine, not cyclo-O~8~-Na^+^, was responsible for the catalase activity expressed in presence of H~2~O~2~ and *C. utilis* RNA under biomimetic conditions.

3.4. Synthesis and characterization of **RC** {#s0145}
---------------------------------------------

It was decided to exactly scale-up (21-fold) the catalase assay protocol starting with cytidine × HCl and *C. utilis* RNA to detect any cyclo-O~8~-Na^+^ formation under biomimetic conditions ([Fig. 2](#f0010){ref-type="fig"}C). From this preparation, a cyclo-O~8~-Na^+^-containing crystalline material **RC** could be isolated which gave not the elemental analysis of cytidine × HCl. If the *C. utilis* RNA was omitted, no product **RC** could be isolated, only cytidine × HCl. Based on ^1^H-NMR spectroscopy (Fig. S8B) and FT--IR spectroscopy (Fig. S10) of **RC**, a formula for **RC** can be constructed: cytidine hydrochloride − μ-chloro(μ-hydroxy)bis(octoxocane-κ^4^ *O* ^1^,*O* ^3^,*O* ^5^,*O* ^7^)disodium (1:2) ([Fig. 2](#f0010){ref-type="fig"}C). We suggest a mechanism for the generation of cyclo-O~8~ from atmospheric O~2~ under ninhydrin catalysis ([Fig. 2](#f0010){ref-type="fig"}D). Ninhydrin can dissociate to the ninhydrinate anion which in the heat could absorb four O~2~ molecules to form an anion of a nonaoxidane. The 10-ring intermediate spiro\[indene-2,10′-nonoxecane\]-1,3-dione could be formed from the nonaoxidanide under acid catalysis, followed by extrusion of cyclo-O~8~.

3.5. Electrospray ionization mass spectrometry of **RC** {#s0150}
--------------------------------------------------------

Final structure proof for the existence of cyclo-O~8~ was obtained from the ESI--MS of **RC** ([Fig. 3](#f0015){ref-type="fig"} and Fig. S11). Cluster cations of heptoxazocan-8-ium − octoxocane − Na^35^Cl (1:2:*m*) (*m*  = 0--6) were observed, together with characteristic + 2 isotope peaks resulting from substitution of one ^37^Cl for ^35^Cl (*m*  = 1--6), and together with − 2 peaks of heptoxazocan-8-iumyl − octoxocane (1:2) cluster radical cations (*m*  = 0--6) ([Fig. 3](#f0015){ref-type="fig"}). Clusters of \[(cytidine)~2~  + Na + (NaCl)~*n*~\]^+^ (*n*  = 0--5) were also observed ([Fig. 3](#f0015){ref-type="fig"}). Structure proving was the missing of a + 2 peak for *m*  = 0 ([Fig. 3](#f0015){ref-type="fig"}, inset), indicating that any NaCl is absent in this radical cation *m*/*z* 383.9907. The nitrogen insertion into cyclo-O~8~ to give heptoxazocane (HNO~7~) results from mass spectrometric generation of ammonia NH~3~ from cytidine (O~8~  + NH~3~ → HNO~7~  + H~2~O). The increased mass error is due to the small intensity (\< 1%) of the cluster cation peaks [@bb0180]. An analogous loss of accuracy (mass error ≥ ± 50 ppm for peak intensity ≤ 1.43%) was reported for DNA oligonucleotide analysis by ESI--MS [@bb0180].Fig. 3Electrospray ionization mass spectrometry of **RC**. Magnified (100 ×) section of the ESI--MS spectrum of **RC** dissolved in H~2~O/methanol from *m*/*z* 430 to *m*/*z* 760. Inset, magnified (20 ×) segment of the ESI--MS spectrum of **RC** from *m*/*z* 370 to *m*/*z* 430. The cluster cations of heptoxazocan-8-ium − octoxocane − Na^35^Cl (1:2:*m*) are marked (*m* = 0--6). Not marked are the + 2 isotope peaks resulting from ^37^Cl instead of one ^35^Cl (*m* = 1--6). The origin of the heptoxazocan-8-iumyl − octoxocane (1:2) cluster radical cations (− 2 peaks) is indicated in the inset. The cluster cations of \[(cytidine)~2~ + Na + (NaCl)~*n*~\]^+^ (*n* = 0--5) are marked with stars.

3.6. Binding of **NC** to *Candida utilis* RNA {#s0155}
----------------------------------------------

In view of the biomimetic generation of the cyclo-O~8~-Na^+^-containing coordination complex **RC**, the question arose if cyclo-O~8~-Na^+^ could bind to nucleic acids, because of the mere electrostatic attraction of the cyclo-O~8~-Na^+^ cation toward the negatively charged phosphate backbone of RNA and DNA. For this purpose, thin-layer chromatographic mobility shift assays [@bb0185] were applied on specific nucleic acids and the cyclo-O~8~-Na^+^ contained in **NC**. Firstly, the affinity of the cyclo-O~8~-Na^+^ toward *C. utilis* low-molecular weight RNA was investigated (Fig. S12). It was found that the cyclo-O~8~-Na^+^ contained in **NC** retained the chromatographic shift of *C. utilis* 5S rRNA, but not the chromatographic shift of *C. utilis* tRNAs. Interestingly, since work conditions were not human skin ribonuclease (RNase)-free, the RNase A digestion products of *C. utilis* 5S rRNA were separated chromatographically (Fig. S12). These dinucleotide 2′,3′-cyclic phosphates (products of RNase A digestion) [@bb0190] result from human skin RNase 7 [@bb0195]-mediated digestion of *C. utilis* 5S rRNA. The structures of these dinucleotides can be deduced [@bb0170], [@bb0175], since RNase 7 belongs to the RNase A superfamily [@bb0195]. The cyclo-O~8~-Na^+^ contained in **NC** bound strongly to these dinucleotide 2′,3′-cyclic phosphates, since their chromatographic shifts were significantly retarded. Controls were included to differentiate the sole binding of cytidine × HCl to the RNA targets by *Watson*--*Crick* base pairing [@bb0200] from the indicative cyclo-O~8~-Na^+^ *plus* cytidine × HCl binding to the RNA targets.

3.7. Binding of **NC** to salmon testes single-stranded DNA and spermine phosphate {#s0160}
----------------------------------------------------------------------------------

Accordingly, the affinity of the cyclo-O~8~-Na^+^ contained in **NC** toward salmon testes single-stranded deoxyribonucleic acid \[ssDNA, generated by sonication of salmon genomic double-stranded DNA (dsDNA)\] was investigated (Fig. S13). It was found that the cyclo-O~8~-Na^+^ contained in **NC** retained the chromatographic shift of cytidine × HCl complexed to ssDNA. As control served cytidine × HCl complexed to ssDNA. *In vivo* DNA-rich preparations are known since 1677 [@bb0205] to be found in close association with spermine phosphate when *Antoni van Leeuwenhoek* discovered the characteristic crystals of spermine phosphate (spermine × 2 H~3~PO~4~  × 6 H~2~O) [@bb0210] in human semen. Therefore, the affinity of the cyclo-O~8~-Na^+^ contained in **NC** toward salmon testes ssDNA in the absence and presence of spermine × 1 ⅓ (sodium dihydrogen phosphate) × 9 H~2~O was investigated (Fig. S14). It was found that the spermine × 1 ⅓ (sodium dihydrogen phosphate) × 9 H~2~O changed the chromatographic shift of the cytidine × HCl in **NC**-complexed ssDNA. As controls served cytidine × HCl complexed to ssDNA in absence and presence of cyclo-O~8~-Na^+^, and cytidine × HCl complexed to ssDNA in the presence of spermine × 1 ⅓ (sodium dihydrogen phosphate) × 9 H~2~O. Taken together, cyclo-O~8~-Na^+^ contained in **NC** has the ability to bind to RNA dinucleotide 2′,3′-cyclic phosphates, eukaryotic 5S rRNA, eukaryotic ssDNA, and to construct a ternary complex with spermine phosphate and eukaryotic ssDNA.

3.8. In vitro biological effects of **NC** and **dNC** on cultured mammalian cells {#s0165}
----------------------------------------------------------------------------------

The *in vitro* biological effects of **NC** and **dNC** on the growth of cultured cells, freshly explanted human primary (human peripheral blood mononuclear cells, PBM cells), immortalized T-lymphoblastic (CCRF--CEM) and monkey kidney normal epithelial (Vero), were investigated (Table S1). **NC** and **dNC** were non-toxic to PBM cells, but stimulated the growth of CCRF--CEM cells. This pointed to a catalase effect exerted by **NC** and **dNC**, since CCRF--CEM cells are extremely sensitive to H~2~O~2~ [@bb0215], and scavenging of H~2~O~2~ by 'catalase factors' is CCRF--CEM cell growth rate-limiting [@bb0215], [@bb0220]. Since **NC** was more active as a growth stimulant for CCRF--CEM cells than **dNC**, the responsible 'catalase factors' should be the nucleoside hydrochlorides, not the equimolar cyclo-O~8~-Na^+^-content in **NC** and **dNC**. **NC** and **dNC** exhibited no significant *in vitro* antiviral activities against the *retro*-transcribing human immunodeficiency type 1 and hepatitis B viruses (HIV-1 and HBV) (Table S1). **NC** showed no significant *in vitro* inhibiting activity versus the replication of influenza A, chikungunya, and Middle East respiratory syndrome viruses (Table S2). In summary, cyclo-O~8~-Na^+^ is, contrary to expectation, essentially non-toxic to human cells, and cytidine in conjunction with RNA acts as a catalyst in producing cyclo-O~8~-Na^+^ from ubiquitous [@bb0225] H~2~O~2~ through a catalase reaction in cultured human cells.

4. Discussion {#s0170}
=============

Our findings have important consequences for the epigenetics [@bb0230] of eukaryotic *in vivo* DNA. We suggest a model for a first epigenetic shell of *in vivo* DNA ([Fig. 4](#f0020){ref-type="fig"} ), based on the observed complexation of cyclo-O~8~-Na^+^ and spermine phosphate to ssDNA. One reason why this protecting shield of *in vivo* DNA was overlooked until now may be its destruction during DNA purification by the classical phenol extraction method of *Schuster*, *Schramm*, and *Zillig* [@bb0235]. In our model ([Fig. 4](#f0020){ref-type="fig"}A), the phosphate backbone of ssDNA binds one cyclo-O~8~-Na^+^ *pro* three nucleotides, and this binary complex binds one spermine monophosphate to form a ternary epigenetic core of DNA. The monohydrogen phosphate bridges the cyclo-O~8~-Na^+^ with the sperminium cation, and the cyclo-O~8~-Na^+^ has an inverted alternating orientation ([Fig. 4](#f0020){ref-type="fig"}A). Interestingly, the sperminium tetracation cannot bind alone to DNA in this model, since the distances \[*d* (*N* ^1^,*N* ^4^) = 490 pm; *d* (*N* ^1^,*N* ^12^) = 1600 pm\] between the four ammonium nitrogens do not fit the average repeating distance (*d* ~Ø~  = 650 ± 30 pm) of the phosphate anion charges of DNA. Therefore, it is quite remarkable that in our model for the first epigenetic shell of *in vivo* DNA ([Fig. 4](#f0020){ref-type="fig"}A) a repeating unit is formed from cyclo-O~8~-Na^+^ and spermine phosphate that perfectly fits both the triplet nature of the genetic code [@bb0240] and the repeating distance of the phosphate anion backbone of DNA.Fig. 4Molecular modeling of the postulated first epigenetic shell of *in vivo* DNA, as exemplified for a single-stranded hexanucleotide, introducing a molecular biological model for sperminium phosphate/cyclo-O~8~-Na^+^/ssDNA and sperminium selenite/cyclo-O~8~-Na^+^/ssDNA interactions. (A) The molecular model of the lysyl--lysine-coding single-stranded hexanucleotide d(ApApApApApAp) liganded with cyclo-O~8~-Na^+^ and sperminium phosphate. (B) The molecular model of d(ApApApApApAp) liganded with cyclo-O~8~-Na^+^ and sperminium selenite. Element color codings for (A) and (B): gray, carbon; white, hydrogen; blue, nitrogen; red, oxygen; purple, phosphorus; green, sodium; yellow, selenium.

Evidence for the correctness of this model results from the published investigation of spermine distribution in bovine lymphocytes [@bb0075]. The theoretical intracellular concentration of the sperminium phosphate/cyclo-O~8~-Na^+^ complex required to cover all triplets of the dsDNA genome in a blood lymphocyte of *Bos taurus* was calculated as 13.8130 mM (see [Section 2.9](#s0075){ref-type="sec"}). The actual concentration of spermine was measured as 1.57 ± 0.12 (mM ± s.d.) [@bb0075]. Therefore, the coverage of *B. taurus* genome can be calculated as 2.62 ± 0.50 (% ± s.d.) (see [Section 2.9](#s0075){ref-type="sec"}). A correlation was obtained when this value was compared to the proportion of protein-coding exons in *B. taurus* genome which was calculated as 2.64% or 2.68% by two independent methods (see [Section 2.9](#s0075){ref-type="sec"}). This points to complete coverage of actively transcribed gene regions in *B. taurus* interphase genome by the sperminium phosphate/cyclo-O~8~-Na^+^ complex. Since spermine binds more strongly to GC-rich dsDNA (pBR322 plasmid) [@bb0075], it can be assumed that the sperminium phosphate/cyclo-O~8~-Na^+^ complex binds preferentially to epigenetic, non-methylated CpG island hotspots [@bb0245] and is involved in epigenetic gene regulation [@bb0245].

Additional evidence for the correctness of the model results from the published concentration of spermine in the metaphase chromatin of eukaryotic HeLa S3 cells [@bb0100]. The content of spermine in HeLa S3 cell metaphase chromatin was calculated as 135.9 ± 16.1 pmol spermine/82.84 zmol dsDNA (see [Section 2.10](#s0080){ref-type="sec"}). This corresponds to 1.64 × 10^9^ molecules spermine (and, hence, of sperminium phosphate/cyclo-O~8~-Na^+^) *pro* one HeLa S3 cell diploid genome, corresponding to a haploid genomic coverage of 12.6%. This is a reasonable result, since spermine synthesis is highest in the metaphase of mitosis in the cell cycle, coincident with an extraordinary high condensation grade of metaphase chromatin [@bb0250]. Control for this *in vitro* result is the published elemental phosphorus content (mmol/kg dry weight) in mitotic chromatin of primary cryptal enterocytes of murine duodenum [@bb0105]. The obtained *in vivo* value corresponds to a haploid genomic coverage of 12.4%, and a nuclear RNA coverage of 77.3%, by the sperminium phosphate/cyclo-O~8~-Na^+^ complex in mitotic chromatin (see [Section 2.11](#s0085){ref-type="sec"}). This points to a function of sperminium phosphate/cyclo-O~8~-Na^+^ occupation for nuclear RNA.

We also wish to elaborate a model for selenium (hydrogen selenite, HSeO~3~ ^−^) protection of DNA. Selenium is essential to mammalian physiology at nutritional levels, but supraphysiological intake of selenium is known to be toxic for mammals [@bb0255], [@bb0260], [@bb0265]. Selenium has the ability to protect DNA from noxious influences (oxidative stress, radiation, cytotoxic agents) [@bb0255] and is essential to genomic stability [@bb0260], but the exact molecular biological basis for these phenomena is unknown. If in our model of a first epigenetic shell of *in vivo* DNA ([Fig. 4](#f0020){ref-type="fig"}A) the monohydrogen phosphate is replaced by hydrogen selenite ([Fig. 4](#f0020){ref-type="fig"}B), an epigenetic explanation for the interaction of selenium with eukaryotic *in vivo* DNA could be given. This model may account for, at least some of, the well-known bimodal, protective and toxic, *in vivo* effects exerted by selenium onto mammalian physiology [@bb0255], [@bb0260], [@bb0265]. A moderate substitution pattern of hydrogen selenite for monohydrogen phosphate would be essential, but if the displacement ratio HSeO~3~ ^−^/HPO~4~ ^2 −^ exceeds a certain tolerance level, the epigenetic equilibrium could collapse.

5. Conclusion {#s0175}
=============

We allow us the profound conclusions that sperminium phosphate/cyclo-O~8~-Na^+^ coverage of nucleic acids is essential for eukaryotic gene regulation, and, in conjunction with selenite, protects and stabilizes gene-rich 'open chromatin' euchromatic DNA [@bb0270] and various nuclear RNAs. These postulations would account for a long-sought molecular explanation of the essential, but 'mysterious' function of the polyamine spermine in eukaryotes [@bb0275]. Spermine is found only in eukaryotes, with some exceptions, and prokaryotes rely mostly on putrescine and spermidine [@bb0275], [@bb0280]. The essentiality of spermine for humans is exemplified by the *Snyder*--*Robinson* X-linked mental retardation syndrome [@bb0285] caused by missense mutations in the human spermine synthase gene, leading to mental retardation, generalized seizures, absent speech, inability to stand, and other severe defects [@bb0285]. One can speculate that at the transition from prokaryotic to eukaryotic life, the sperminium phosphate/cyclo-O~8~-Na^+^ complex resulted as a consequence from the combined accumulation of atmospheric oxygen and prokaryotic RNA, since the evolution of spermine synthases from prokaryotic spermidine synthase was proposed [@bb0280] as co-occurring with the onset of proto-eukaryotic life.
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